Compare FGEN & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FGEN | JG |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 39.4M |
| IPO Year | 2014 | 2018 |
| Metric | FGEN | JG |
|---|---|---|
| Price | $8.36 | $6.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $146.50 | N/A |
| AVG Volume (30 Days) | ★ 40.1K | 4.8K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 53.38 | N/A |
| Revenue | $8,298,000.00 | ★ $50,967,244.00 |
| Revenue This Year | N/A | $10.90 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.16 | ★ N/A |
| Revenue Growth | N/A | ★ 20.78 |
| 52 Week Low | $4.85 | $5.74 |
| 52 Week High | $21.94 | $20.94 |
| Indicator | FGEN | JG |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 47.29 |
| Support Level | $7.99 | $6.52 |
| Resistance Level | $8.55 | $6.87 |
| Average True Range (ATR) | 0.33 | 0.28 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 49.45 | 83.74 |
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.